Rakhee Vaidya

3.8k total citations · 2 hit papers
43 papers, 2.1k citations indexed

About

Rakhee Vaidya is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Rakhee Vaidya has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 19 papers in Hematology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Rakhee Vaidya's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Lymphoma Diagnosis and Treatment (13 papers) and Acute Myeloid Leukemia Research (9 papers). Rakhee Vaidya is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Lymphoma Diagnosis and Treatment (13 papers) and Acute Myeloid Leukemia Research (9 papers). Rakhee Vaidya collaborates with scholars based in United States, Italy and Germany. Rakhee Vaidya's co-authors include Ayalew Tefferi, Animesh Pardanani, Domenica Caramazza, Naseema Gangat, Christy M. Finke, Terra L. Lasho, Curtis A. Hanson, Kebede H. Begna, Thomas E. Witzig and Susan M. Schwager and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Rakhee Vaidya

39 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

2010 657 citations Naseema Gangat, Domenica Caramazza et al. Journal of Clinical Oncology profile →
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

2011 435 citations Ayalew Tefferi, Rakhee Vaidya et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rakhee Vaidya United States	13	1.6k	1.3k	897	625	282	43	2.1k
Carlos Besses Spain	22	1.4k 0.8×	919 0.7×	845 0.9×	525 0.8×	227 0.8×	78	1.8k
Margherita Maffioli Italy	20	2.5k 1.5×	2.5k 1.9×	1.4k 1.6×	729 1.2×	126 0.4×	61	3.1k
Ester Pungolino Italy	16	1.6k 1.0×	1.4k 1.1×	864 1.0×	538 0.9×	196 0.7×	39	2.0k
Eva Löfvenberg Sweden	18	813 0.5×	988 0.8×	362 0.4×	166 0.3×	229 0.8×	32	1.4k
Jean‐Didier Rain France	16	808 0.5×	595 0.5×	385 0.4×	325 0.5×	345 1.2×	32	1.5k
Nicola Polverelli Italy	20	559 0.3×	974 0.8×	308 0.3×	210 0.3×	131 0.5×	71	1.3k
Cesare Astori Italy	14	735 0.4×	497 0.4×	472 0.5×	237 0.4×	224 0.8×	29	1.0k
C. Astori Italy	13	764 0.5×	574 0.5×	471 0.5×	281 0.4×	260 0.9×	22	1.1k
Susan O’Brien United States	15	1.4k 0.8×	997 0.8×	259 0.3×	218 0.3×	933 3.3×	24	2.2k
Domenica Caramazza Italy	19	2.3k 1.4×	1.9k 1.5×	1.3k 1.5×	785 1.3×	64 0.2×	35	2.6k

Countries citing papers authored by Rakhee Vaidya

Since Specialization

Citations

This map shows the geographic impact of Rakhee Vaidya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rakhee Vaidya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rakhee Vaidya more than expected).

Fields of papers citing papers by Rakhee Vaidya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rakhee Vaidya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rakhee Vaidya. The network helps show where Rakhee Vaidya may publish in the future.

Co-authorship network of co-authors of Rakhee Vaidya

This figure shows the co-authorship network connecting the top 25 collaborators of Rakhee Vaidya. A scholar is included among the top collaborators of Rakhee Vaidya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rakhee Vaidya. Rakhee Vaidya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vaidya, Rakhee, Hamid Ehsan, Tamara K. Moyo, et al.. (2024). Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma. Transplantation and Cellular Therapy. 30(11). 1082.e1–1082.e10. 4 indexed citations

Moyo, Tamara K. & Rakhee Vaidya. (2024). Re-examining the role of hematopoietic stem cell transplantation in relapsed large B-cell lymphoma in the era of chimeric antigen receptor (CAR) T-cell therapy. Frontiers in Oncology. 14. 1397186–1397186. 1 indexed citations

Vaidya, Rakhee, et al.. (2023). Haploidentical Transplant Using a Novel Preparative Regimen: An Update on a New Standard of Care for Patients without HLA Matched Donors. Transplantation and Cellular Therapy. 29(2). S239–S240.

Hsi, Eric D., et al.. (2022). Clinical Reasoning: A 65-year-old Woman with Cancer History and Wrist Drop (P15-9.001). Neurology. 98(18_supplement). 1 indexed citations

Vaidya, Rakhee, et al.. (2021). Development and Implementation of Outpatient CAR-T Program at the Wake Forest Baptist Comprehensive Cancer Center. Transplantation and Cellular Therapy. 27(3). S315–S315. 1 indexed citations

McPhail, Ellen D., Matthew J. Maurer, William R. Macon, et al.. (2018). Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements. Haematologica. 103(11). 1899–1907. 46 indexed citations

Wan, Siu‐Hin, Jackson J. Liang, Rakhee Vaidya, Joseph L. Blackshear, & Dong Chen. (2014). Acquired Von Willebrand Syndrome Secondary to Mitral and Aortic Regurgitation. Canadian Journal of Cardiology. 30(9). 1108.e9–1108.e10. 11 indexed citations

Vaidya, Rakhee, Rajiv K. Pruthi, & Carrie A. Thompson. (2013). An unusual presentation of heparin-induced thrombocytopenia in the setting of catheter-directed ablation of atrial fibrillation. Blood Coagulation & Fibrinolysis. 25(2). 188–190.

Vaidya, Rakhee & Keith M. Swetz. (2013). Urinoma presenting as an abscess in an immunocompromised host: a case report. Journal of Medical Case Reports. 7(1). 193–193. 2 indexed citations

10.

Vaidya, Rakhee, Thomas M. Habermann, J H Donohue, et al.. (2013). Bowel perforation in intestinal lymphoma: incidence and clinical features. Annals of Oncology. 24(9). 2439–2443. 100 indexed citations

11.

Khanna, Sahil, et al.. (2012). Epstein-Barr virus-associated nephrotic syndrome. Clinical Kidney Journal. 5(1). 50–52. 12 indexed citations

12.

Kloesel, Benjamin, Rakhee Vaidya, Matthew T. Howard, & Carrie A. Thompson. (2012). A unifying diagnosis for pancytopenia, fever, hypoglycemia, and lactic acidosis. American Journal of Hematology. 88(1). 78–81. 1 indexed citations

13.

Tefferi, Ayalew, Terra L. Lasho, Thitina Jimma, et al.. (2012). One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience. Mayo Clinic Proceedings. 87(1). 25–33. 174 indexed citations

14.

Tefferi, Ayalew, Rakhee Vaidya, Domenica Caramazza, et al.. (2011). Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study. Journal of Clinical Oncology. 29(10). 1356–1363. 435 indexed citations breakdown →

15.

Vaidya, Rakhee, Richa Sood, Nina J. Karlin, & Aminah Jatoi. (2011). Benzodiazepine Use in Breast Cancer Survivors: Findings from a Consecutive Series of 1,000 Patients. Oncology. 81(1). 9–11. 11 indexed citations

16.

Vaidya, Rakhee, Nanna Sulai, Sania S. Raza, et al.. (2011). Comprehensive Plasma Cytokine Profiling in Polycythemia Vera: Comparison with Myelofibrosis and Clinical Correlates,. Blood. 118(21). 3850–3850. 2 indexed citations

17.

Tefferi, Ayalew, Elisa Rumi, Guido Finazzi, et al.. (2011). Survival and Prognosis Among 1,263 Patients with Polycythemia Vera: An International Study. Blood. 118(21). 277–277. 10 indexed citations

18.

Gangat, Naseema, Domenica Caramazza, Rakhee Vaidya, et al.. (2010). DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status. Journal of Clinical Oncology. 29(4). 392–397. 657 indexed citations breakdown →

19.

Caramazza, Domenica, Kebede H. Begna, Naseema Gangat, et al.. (2010). Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients. Leukemia. 25(1). 82–88. 119 indexed citations

20.

Vaidya, Rakhee, Sergio Siragusa, Jocelin Huang, et al.. (2009). Mature Survival Data for 176 Patients Younger Than 60 Years With Primary Myelofibrosis Diagnosed Between 1976 and 2005: Evidence for Survival Gains in Recent Years. Mayo Clinic Proceedings. 84(12). 1114–1119. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact